The Key Metrics Behind Risk Stratification
I’m Aware That I’m Rare: the phaware® podcast
Episode 533 - Robert Frantz, MD
Dr. Robert Frantz breaks down the key metrics behind risk stratification — functional class, six-minute walk distance, and brain natriuretic peptide levels — and explains how they shape treatment plans. He also explores the role of echocardiography, right heart catheterization, and cutting-edge therapies in improving patient outcomes.
Before PAH Strikes: Why Early Detection Could Change Everything
I’m Aware That I’m Rare: the phaware® podcast
Episode 514 - Eric Austin, MD, MSCI
Eric Austin, MD, MSCI discusses early detection among people who are at risk of pulmonary arterial hypertension (PAH), particularly those who would have genetic susceptibility, or who may have congenital heart disease, or who may have connective tissue disease or other features that would make them more at risk of developing pulmonary arterial hypertension than the rest of the population.